Search the Newsreel

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

Pomerantz LLP is investigating potential claims on behalf of investors of Teladoc Health, Inc. (NYSE: TDOC) concerning alleged securities fraud or unlawful business practices. This investigation follows Teladoc's updated 2026 revenue guidance, which was significantly lowered due to "uncertainties inherent in cash pay and …

Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating Teladoc Health, Inc. (TDOC) on behalf of investors following a significant drop in its stock price. This drop occurred after Teladoc reported lower-than-expected Q2 2026 revenue and subsequently reduced its full-year 2026 revenue guidance. The firm cites …

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has initiated a securities fraud investigation into Teladoc Health Inc. (TDOC) following a significant drop in its stock price. This investigation comes after Teladoc reduced its full-year revenue guidance and reported a more drastic reduction in BetterHelp's …

TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates

TELA Bio, Inc. (TELA) CEO discloses 5,000-share ownership stake

TELA Bio, Inc.'s CEO, Heather C. Getz, has filed an initial statement of beneficial ownership, reporting a direct holding of 5,000 shares of common stock as of August 3, 2026. This Form 3 filing establishes her initial reported equity position as an insider, with …

TELA Bio Grants CEO 2.37M Stock Options | TELA Stock News

TELA Bio (NASDAQ: TELA) announced inducement equity grants for its new CEO, Heather Getz, and 11 new employees under Nasdaq Listing Rule 5635(c)(4). Ms. Getz received options to purchase 2,370,000 shares and restricted stock units (RSUs) for 500,000 shares, with specific exercise prices and …

Large equity grants for TELA Bio, Inc. (TELA) CEO Heather Getz

TELA Bio, Inc. CEO Heather C. Getz received substantial equity awards on August 3, 2026, including 500,000 restricted stock units (RSUs) and options for 2,370,000 shares of common stock. The RSUs and stock options have multi-year vesting schedules contingent on her continued service. These …

Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC

Dimensional Fund Advisors LP significantly reduced its stake in Teladoc Health, Inc. by 16% in the first quarter, selling 1.2 million shares but still retaining over 6.3 million shares valued at approximately $34.3 million. Despite beating EPS estimates, Teladoc's revenue declined year-over-year and missed …

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for investors who purchased Teladoc Health securities, especially …

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio, Inc. announced inducement grants of stock options and restricted stock units to its newly-hired Chief Executive Officer, Heather Getz, and 11 other new employees. These grants were approved under Nasdaq Rule 5635(c)(4) as a material inducement for their employment. The grants for …

Teladoc Health (NYSE: TDOC) director Mark Anquillare submits initial Form 3

Teladoc Health Inc. (NYSE: TDOC) director Mark V. Anquillare has filed an initial Form 3, indicating his beneficial ownership of securities as a director. The filing reports no equity transactions and includes a reference to a Power of Attorney. This Form 3 establishes Anquillare's …

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Director Anquillare Mark V

This article reports a change in the beneficial ownership of securities for Mark V. Anquillare, a Director at Teladoc Health. The filing is a Statement of Changes in Beneficial Ownership, also known as a Form 4. This indicates that there has been a transaction …

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

TELA Bio, Inc. has appointed Heather Getz as its new Chief Executive Officer and Director, effective August 4, 2026. Ms. Getz brings extensive experience from previous executive roles at Butterfly Network, Inc. and BioTelemetry, Inc., where she demonstrated a strong track record in driving …

Teladoc Health

This article provides an overview of Teladoc Health (TDOC), a company specializing in telehealthcare services. It details the company's profile, including its founding, headquarters, CEO, and employee count, alongside key financial statistics, stock price performance, and analyst consensus recommendations.

Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC)

Teladoc Health director Mark V. Anquillare was granted 37,425 Restricted Stock Units (RSUs) on August 3, 2026. These RSUs, which represent a contingent right to one share of common stock each, will vest in a staggered manner: one-third on the first anniversary of the …

Teladoc Health (TDOC) On Weaker Earnings And Guidance The Fair Value Debate Returns

Teladoc Health (TDOC) is facing renewed scrutiny after reporting weaker Q2 revenue, a wider net loss, and reduced full-year guidance, leading to a significant stock pullback. Despite a narrative suggesting the stock is 55.5% undervalued with a fair value of $15.00 due to its …

Heather Getz named CEO of TELA Bio as Antony Koblish exits

TELA Bio has appointed Heather Getz as its new Chief Executive Officer and a Class II director, effective August 3, 2026. This appointment follows the departure of Antony Koblish, who ceased serving as CEO and resigned from the board on the same date. Getz …

TELA Bio appoints Heather Getz as chief executive officer By Investing.com

TELA Bio, Inc. has announced the appointment of Heather Getz as its new Chief Executive Officer and Director, effective immediately. Getz previously held executive positions at Butterfly Network, Inc. and BioTelemetry, Inc., where she oversaw significant market capitalization growth. She succeeds co-founder Antony Koblish, …

TELA Bio names former Butterfly Network executive as CEO

TELA Bio (NASDAQ: TELA) has appointed Heather Getz as its new Chief Executive Officer and Director, effective August 4, 2026. Getz previously held executive roles at Butterfly Network and BioTelemetry, where she significantly contributed to strategic growth and increased market capitalization. The company expressed …

Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026

Teladoc Health, Inc. has announced the appointment of Mark V. Anquillare to its board of directors, effective August 3, 2026. Mr. Anquillare, former president and COO of Verisk Analytics, brings over 30 years of financial and executive leadership experience. He will serve on the …

The 5 Most Interesting Analyst Questions From Teladoc’s Q2 Earnings Call

Stelar Metals Limited (ASX: SLB) Appoints ex-Core Lithium Exploration Manager

Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors

Teladoc Health (NYSE: TDOC) has announced the appointment of financial executive Mark V. Anquillare to its board of directors. Mr. Anquillare, former president and chief operating officer of Verisk Analytics, will serve on the board’s Audit & Compensation committees, bringing over 30 years of …

Teladoc Health | 8-K: Current report

This document is an 8-K current report filed by Teladoc Health. The content of the report itself is not provided in the input, only the document type.

TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health

SueWallSt is investigating potential securities law violations by Teladoc Health (TDOC) after the company cut its full-year 2026 revenue guidance, leading to a nearly 30% drop in stock value. The investigation focuses on whether Teladoc made false or misleading statements about its revenue outlook. …

Are Investors Undervaluing Teladoc Health (TDOC) Right Now?

The article analyzes why Teladoc Health (TDOC) might be undervalued, highlighting its Zacks Rank #2 (Buy) and an "A" grade for Value. It uses metrics like P/B, P/S, and P/CF ratios to demonstrate that TDOC's valuation is attractive compared to its industry averages. The …

Stelar Metals hires ex-Core Lithium exploration chief for maiden tungsten drilling

Stelar Metals (ASX:SLB) Crashes 12.50%: Is the Market Overreacting—or Spotting Trouble Early?

Teladoc Health: Insurance Demand Outpaces Provider Capacity As BetterHelp Revenue Falls 12%

Teladoc Health's BetterHelp division experienced a significant shift towards insurance-covered therapy, leading to a 12% revenue decline as increased demand outpaced provider capacity and could not offset a sharp drop in cash-pay customers. While insurance-covered services saw over a tenfold revenue increase, the transition …

Stelar Metals raises A$2.6m to fast-track Hill of Leaders tungsten drilling

Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed?

Teladoc Health (TDOC) reported a challenging Q2 2026 with declining sales, a wider net loss, and lowered full-year 2026 guidance, primarily due to struggles in its BetterHelp mental health unit as users shift to insurance-covered care. This performance pressures the company's investment narrative, which …

TELA Bio Inc Today's Market Trends | TELA Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

This article provides a detailed analysis of TELA Bio Inc (TELA) stock, including its current market trends, financial data, and analyst ratings. It highlights the company's strong fundamentals, significant growth potential, and high institutional ownership, despite a recent weak stock market performance. The analysis …

Teladoc Health Number of Employees 2026 | Employee Count & Headcount Data

Teladoc Health (TDOC) had 5,704 employees worldwide as of March 2026, marking a 1.7% decline from 2023 but a recovery from a low in 2025. The company is actively hiring with 611 job postings in 2026, and its workforce is primarily concentrated in the …

Teladoc Health Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Teladoc Health (TDOC)

Levi & Korsinsky, LLP has announced an investigation into Teladoc Health (TDOC) after the company's stock dropped over 28% following a disappointing Q2 2026 earnings report and reduced full-year revenue guidance. The investigation focuses on whether Teladoc made false or misleading statements regarding its …

Teladoc Health (TDOC) Could Be 56% Undervalued As Weak Results Reset Expectations

Teladoc Health (TDOC) shares have seen a significant drop after reporting weaker-than-expected Q2 2026 results and revised guidance. Despite recent poor performance, one valuation narrative suggests TDOC could be 56% undervalued with a fair value of $15.00, driven by potential success in its BetterHelp …